You are here

  • Home
  • Archive
  • Volume 30, Issue 9
  • BET 1: Intranasal lorazepam is an acceptable alternative to intravenous lorazepam in the control of acute seizures in children

Article metrics

Article menu
Download PDFPDF
Best Evidence Topic Reports
BET 1: Intranasal lorazepam is an acceptable alternative to intravenous lorazepam in the control of acute seizures in children

 

Online download statistics by month:

Online download statistics by month: August 2013 to January 2023

AbstractFullPdf
Aug 20133291540
Sep 20131311219
Oct 20139438
Nov 20138844
Dec 20133422
Jan 20141934
Feb 20144113
Mar 20142212
Apr 20143114
May 20142145
Jun 20141311
Jul 20141943
Aug 20141611
Sep 20141455
Oct 20142012
Nov 2014935
Dec 20141313
Jan 20151323
Feb 20151012
Mar 20151643
Apr 20151814
May 2015722
Jun 20152341
Jul 20151500
Aug 2015713
Sep 20152635
Oct 20151110
Nov 20151511
Dec 20151454
Jan 20162444
Feb 20162101
Mar 2016600
Apr 20161211
May 20161010
Jun 20162202
Jul 20161413
Aug 20162602
Sep 20162000
Oct 20161822
Nov 20161810
Dec 20161614
Jan 20171221
Feb 20172931
Mar 201725122
Apr 20172812
May 20172111
Jun 20172632
Jul 20173501
Aug 20177133
Sep 20173800
Oct 20176221
Nov 20176421
Dec 20175920
Jan 20187821
Feb 20185000
Mar 20189430
Apr 20187340
May 20186421
Jun 20185155
Jul 20184410
Aug 20186101
Sep 20186020
Oct 20184021
Nov 20184051
Dec 20183900
Jan 20194600
Feb 20196400
Mar 20194430
Apr 20195151
May 20198162
Jun 20195800
Jul 20195420
Aug 20196730
Sep 20198111
Oct 20195411
Nov 20195641
Dec 20196602
Jan 20205710
Feb 20204911
Mar 20202811
Apr 20202721
May 20201911
Jun 20203852
Jul 20204952
Aug 20203720
Sep 20205911
Oct 20202632
Nov 20203311
Dec 202044101
Jan 20211200
Feb 20212631
Mar 20213400
Apr 20218710
May 20211141
Jun 2021210
Jul 2021310
Oct 20213111
Nov 20214210
Dec 20212532
Jan 20223020
Feb 20221900
Mar 20221800
Apr 20221800
May 20222300
Jun 2022800
Jul 20222000
Aug 20222400
Sep 2022200
Oct 20221600
Nov 20221711
Dec 20222531
Jan 20234511
Total4186235212